Liraglutide (Saxenda; Novo Nordisk) significantly reduces body weight in children ages 6 to 11 with obesity when combined with changes in lifestyle, results of the SCALE Kids trial show. The mean ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results